Eosinophilic Granulomatosis Market 2021-2027: Industry Analysis, Trends, Growth, Opportunities, and Forecast

The Eosinophilic Granulomatosis Market size is expected to grow at an annual average of 6% during 2021-2027. Eosinophilic granulomatosis, also known as Churg-Strauss syndrome, is a rare autoimmune disease characterized by multiple signs and symptoms such as acute asthma, inflammation, sinusitis, and nerve damage. According to recent data from 2019, the prevalence of eosinophilic granulomatosis ranges from 1/100,000 to 1/70,000 in Europe, and is much more frequent in asthmatics (approximately 1/15,000).A combination of drug therapies is preferred for treatment of eosinophilic granulomatosis. The classes of drugs used to treat eosinophilic granulomatosis are anti-inflammatory drugs, immunosuppressants, biologics, and immunoglobulins.

The following segmentation are covered in this report:

Based on the distribution channels

• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• Online Pharmacies

Based on route of administration

• Oral
• Intravenous
• Intramuscular

Based on drug class

• Corticosteroids
• Immunosuppressive Agents
• Biologics
• Immune Globulins

Company Profile

• AstraZeneca plc
• GlaxoSmithKline LLC
• Baxter Healthcare Corporation
• Genentech Inc
• Teva Pharmaceutical Industries Ltd
• Koninklijke DSM NV
• Novartis International AG
• Pharma Holdings

Scope of the report

The research study analyses the Eosinophilic Granulomatosis Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Eosinophilic Granulomatosis Market Report

• What was the Eosinophilic Granulomatosis Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Eosinophilic Granulomatosis Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.